Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) [Trend Analysis] knocking active thrust in leading trading session, shares a decrease of -20.90% to 4.39 with about 4.97 Million shares have changed hands in this session. Biostar Pharmaceuticals, Inc. (BSPM) released that it will launch its new topical health product called “Easy Breathing” deinked to treat rhinitis and sinusitis for sales in the PRC in November 2016. Rhinitis is irritation and inflammation of the mucous membrane inside the nose. Sinusitis is an inflammation or swelling of the tissue lining the sinuses.
This new product was developed by the Firm’s R&D team over the past 3 years. Having being developed based upon the principles of the traditional Chinese medicine, the product is deinked to have effects of relieving stuffy nose, inhibiting nasal bacteria and viruses, and mitigating effects on the inflammation of nasal mucosa. It will be manufactured, distributed and sold in the PRC. The stock is going forward its fifty-two week low with 306.48% and lagging behind from its 52-week high price with -37.82%.
Same, the positive performance for the quarter recorded as 10.30% and for the year was -12.90%, while the YTD performance remained at 56.79%. BSPM has Average True Range for 14 days of 0.74.
Amazon.com, Inc. (NASDAQ:AMZN) [Trend Analysis] retains strong position in active trade, as shares scoring 0.37% to $834.09 in a active trade session, while looking at the shares volume, about 2.37 Million shares have changed hands in this session. Amazon.com Inc. (AMZN) reported that it is pushing deeper into the grocery business with plans to introduce convenience stores as well as curbside pickup locations, say people familiar with the matter. The Seattle firm aims to build small brick-and-mortar stores that would sell produce, milk, meats and other perishable items that consumers can take home, these people say. Primarily using their mobile phones or, possibly, touch screens about the store,… The firm has institutional ownership of 66.50%, while insider ownership included 17.10%. AMZN attains analyst recommendation of 1.90 with week’s performance of -1.22%. Investors looking additional ahead will note that the Price to next year’s EPS is 80.22%.